Regenexx Corporate Competitors, Revenue and Alternatives

Claim your profile


Des Moines, IA USA
Total Funding:N/A
Lead Investor(s):N/A

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Regenexx Corporate's estimated annual revenue is currently $12.9M per year.
  • Regenexx Corporate's estimated revenue per employee is $155,000

Employee Data

  • Regenexx Corporate has 83 Employees.
  • Regenexx Corporate grew their employee count by 24% last year.
  • Regenexx Corporate currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingPricing
Regenexx Corpor...
Integrated DNA ...
Percival Scient...
Farm Service Co...
Kemin Industrie...
Trans Ova Genet...
Diamond V
Missing a competitor? Contribute!?

Regenexx was the first to use stem cells to treat orthopedic injuries, and we've published roughly half of all worldwide research in their application. With more than 2.5 million covered lives across the country, Regenexx uses our advanced regenerative technologies to help self-funded employers save 80% on their orthopedic healthcare costs by providing an effective, low-cost alternative to roughly 70% of orthopedic surgeries. When given the choice between a Regenexx procedure and orthopedic surgery, 99% of employees choose Regenexx. The Regenexx process of treating musculoskeletal conditions involves a high level of physician skill and our patented, research-based protocols that allow us to realize outcomes that can only be achieved through our high standards of practice. We license our patented Interventional Orthopedics procedures to physicians across the country who are part of the Regenexx network. These expert physicians receive intensive initial and ongoing training and support. We additionally offer a one-year fellowship in Interventional Orthopedics. Learn more about Regenexx and how we can help you take control of your health care spend. Visit for more information.



Number of Employees


Revenue (est)


Current Jobs


Employee Growth %


Total Funding







Regenexx Corporate News

09/05/2019 - Innovative Report on Autologous Stem Cell and Non-Stem ...

Click here to get Sample Report on Your Corporate Email Id@ ... Caladrius Biosciences, Opexa Therapeutics, Orgenesis, Regenexx, Genzyme, ...

06/20/2019 - Stem Cell Company Persuades Employers To Steer Workers ...

Perhaps Regenexx's best-known corporate client is Des Moines-based Meredith Corp., which owns multiple TV and radio stations, as well as ...

06/19/2019 - Employers Are Steering Workers Toward Controversial Stem ...

In a marketing booklet, Regenexx, whose injections range in price from $1,500 to ... Perhaps Regenexx's best-known corporate client is Des ...